When.com Web Search

  1. Ads

    related to: best mouthwash for chronic halitosis patients with diabetes

Search results

  1. Results From The WOW.Com Content Network
  2. The 4 safest and most effective mouthwashes to use ... - AOL

    www.aol.com/4-safest-most-effective-mouthwashes...

    These dental experts recommend these picks for remedying bad breath, cavities, sensitivity and more. The 4 safest and most effective mouthwashes to use, according to dentists and a gum surgeon ...

  3. These Dentist-Approved Mouthwashes Will Zap Bad Breath and ...

    www.aol.com/dentist-approved-mouthwashes-zap-bad...

    Pro-Health Advanced Mouthwash. This multi-tasking rinse will address many issues at once: bad breath, gingivitis plaque, and gum disease with the active ingredient sodium fluoride.Plus, it’s ...

  4. Study: Heavy mouthwash use linked to higher risk of type 2 ...

    www.aol.com/article/news/2017/11/27/study-heavy...

    A new study out of Harvard University makes a baffling connection between mouthwash and type 2 diabetes.

  5. Dentyl pH - Wikipedia

    en.wikipedia.org/wiki/Dentyl_pH

    Dentyl Dual Action, previously known as Dentyl Active, and originally as Dentyl pH, is a brand of mouthwash, an oral hygiene product designed to reduce the presence of bacteria responsible for tooth decay, gingivitis and halitosis. Traditional mouthwash formulations typically use alcohol or other antimicrobial ingredients to kill bacteria.

  6. Listerine - Wikipedia

    en.wikipedia.org/wiki/Listerine

    Listerine (/ ˈ l ɪ s t ər iː n /) is a brand of antiseptic mouthwash that is promoted with the slogan "Kills germs that cause bad breath". Named after Joseph Lister, who pioneered antiseptic surgery at the Glasgow Royal Infirmary in Scotland, Listerine was developed in 1879 by Joseph Lawrence, a chemist in St. Louis, Missouri.

  7. Biotene - Wikipedia

    en.wikipedia.org/wiki/Biotene

    "A phase II study of Biotène in the treatment of postradiation xerostomia in patients with head and neck cancer”. Support Care Cancer (2000) 8: 203. doi : 10.1007/s005200050286